Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Golvatinib shows promise as a treatment for Omicron in elderly patients.

JAK inhibitors effectively treat skin conditions and topical forms are safer.

The research found new potential mechanisms in mouse hair growth by studying RNA interactions.

Hox proteins help maintain keratinocyte identity by regulating miRNA expression.

Teriflunomide is safe and tolerable for treating relapsing-remitting multiple sclerosis, with manageable side effects.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

EH-MSCs may help treat hair loss by boosting regeneration and reducing inflammation.

Contact immunotherapy can change immune responses in alopecia areata, suggesting new treatment targets.

NKG2D+CD4+ T cells are higher in alopecia areata patients and may be involved in the disease.

FOXN1 mutations cause severe immunodeficiency, hair loss, nail issues, and thymus defects.

Restoring hair follicle immune privilege may help treat alopecia areata.

Salivary vitamin D and IL-6 could help diagnose and manage non-scarring alopecia.

Benign follicular mucinosis involves immune cells attacking hair follicles.

JAK inhibitors show promise for treating various skin disorders effectively and safely.

PIKFyve is essential for normal platelet function and its deficiency causes organ issues and macrophage infiltration.

ICAM-1 helps regulate hair growth cycles and skin remodeling.

Resident memory T cells and necroptosis may drive fibrosis in eosinophilic fasciitis and morphea.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

CD4 T cells can cause alopecia areata by activating CD8 T cells to attack hair follicles.

The skin's immune system helps it regenerate and fight infections.

WNT5A contributes to keloid scars by promoting cell changes through specific signaling pathways.

KLB and EIF3C genes are key for early diagnosis of vitiligo and alopecia areata.

Targeting the HEDGEHOG-GLI1 pathway could help treat keloids.

Type 1 Diabetes prevents hair growth by causing cell death in hair follicles.

Intensive immunosuppression can reduce relapse rates in multiple sclerosis patients, despite some side effects.

Calcineurin inhibitors, used in kidney transplants, can cause a wide range of side effects including kidney damage and other health issues.

Cyclosporine can cause a unique skin condition called "cyclosporine-induced folliculodystrophy."

Skin inflammation can worsen intestinal inflammation and colitis.